![Jane Grogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Grogan
Hoofd Techniek/Wetenschap/O&O bij
BIOGEN INC.
Vermogen: 795 368 $ op 31-05-2026
Profiel
Jane Grogan is Executive Vice President & Head-Research at Biogen, Inc. since 2023.
Former roles include Chief Scientific Officer at Graphite Bio, Inc. from 2021 to 2023, Chief Scientific Officer at Arsenal Biosciences, Inc. from 2019 to 2021, and Head-Adaptive Tumor Immunity & Principal Scientist at Genentech, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Melbourne and a doctorate from the University of Leiden.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-02-2026 | 4.058 ( 0% ) | 795 368 $ | 31-05-2026 |
Actieve functies van Jane Grogan
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOGEN INC. | Hoofd Techniek/Wetenschap/O&O | 02-10-2023 |
Eerdere bekende functies van Jane Grogan
| Bedrijven | Functie | Einde |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-09-2019 |
Opleiding van Jane Grogan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
91
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
